Skip to main content
Caplight Logo









Dexora Technology

Dexora Technology

Private
Clayton SouthHealthcare & Life Scienceshttps://dexora.ai/

Last Round

Accelerator

Feb 12, 2025

Company Overview

Dexora Technology is a health technology company that provides an AI-driven generative design platform and 3D printing services to digitize the orthotics and prosthetics workflow.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Vertical SaaS, Smart Manufacturing

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

orthotics and prostheticsO&P3D printingautomated design platformADPmedical 3D printinggenerative designdigital manufacturingvertical SaaSmedical device manufacturingprosthetic design softwareCAD automationdigital healthmedtech3D printing software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dexora Technology Comparables

Compare Dexora Technology with similar companies based on industry and business-model similarity.

Dexora Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vytruve
83%
Taika3D
82%
Mecuris
82%

Dexora Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 12, 2025

Dexora Technology Investors

Notable investors and investment history

Dexora Technology investors
InvestorRounds
ANDHealthAccelerator
RemarkableAccelerator
Flying Fox VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2025

    Raised an Accelerator round with Flying Fox Ventures, ANDHealth, Remarkable, and RMIT University.

Dexora Technology Filings

Explore SEC and related filing metadata, where available.

Dexora Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dexora Technology's valuation, stock price, and market status.

Is Dexora Technology a public or private company?

Dexora Technology is a private company.

What is the current stock price of Dexora Technology?

Dexora Technology is a private company with no public stock price. No recent secondary market data is available.

How much is Dexora Technology worth (valuation)?

Valuation information for Dexora Technology is not publicly available.

Can I buy Dexora Technology stock?

Dexora Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dexora Technology's last funding round?

Dexora Technology's most recent funding round was Accelerator on February 12, 2025.

Who are the main investors in Dexora Technology?

Key investors in Dexora Technology include ANDHealth, Remarkable, Flying Fox Ventures.

Will Dexora Technology IPO soon?

No public IPO plans have been announced for Dexora Technology.

How can I track Dexora Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dexora Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersClayton South
Employee Range2
Year Founded2024
Last FundingFeb 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?